Parliament Workbench
Data: Motions & questions to 26 Nov 2026

Written Question · S7W-02186 · Session 7

What engagement it has had with NHS England regarding the deployment of fractional exhaled nitric oxide testing for asthma in primary care …

Answered Asked by Willie Rennie LD Lodged 30 Jul 2026

The question

To ask the Scottish Government what engagement it has had with NHS England regarding the deployment of fractional exhaled nitric oxide testing for asthma in primary care settings, and what assessment it has made of the experience of using such tests in England to inform its approach.

The answer

Answered by Maree Todd on 13 Aug 2026 · 14 days after it was lodged, on time

The Scottish Government has not undertaken a formal assessment of the deployment of FeNO testing in primary care settings in England. However, it continues to consider relevant evidence, guidance and learning from across the UK, including experience from England where appropriate, when considering the implementation of respiratory clinical guidance.However, the Scottish Government is aware of developments in the use of fractional exhaled nitric oxide (FeNO) testing across the UK and notes that FeNO testing is recommended within the updated joint British Thoracic Society (BTS), National Institute for Health and Care Excellence (NICE) and Scottish Intercollegiate Guidelines Network (SIGN) guideline on the diagnosis, monitoring and management of asthma. The guideline recommends the use of objective testing, including FeNO testing, to support asthma diagnosis and management.

In the Official Report

No contribution in the Official Report cites S7W-02186 by reference.